Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.85
+0.23 (2.39%)
At close: Jan 14, 2026, 4:00 PM EST
9.80
-0.05 (-0.51%)
After-hours: Jan 14, 2026, 7:59 PM EST
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 834 employees as of December 31, 2024. The number of employees decreased by 384 or -31.53% compared to the previous year.
Employees
834
Change (1Y)
-384
Growth (1Y)
-31.53%
Revenue / Employee
$216,554
Profits / Employee
-$407,129
Market Cap
559.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Dec 31, 2020 | 495 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DNA News
- 1 day ago - Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 23 days ago - Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment - PRNewsWire
- 4 weeks ago - ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies - GlobeNewsWire
- 5 weeks ago - Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC - PRNewsWire
- 6 weeks ago - STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy - PRNewsWire
- 2 months ago - Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health - PRNewsWire